Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

[Reversing paclitaxel-resistance of SKOV3-TR30 cell line by curcumin].

Qiu J, Fu YF, Cheng Q, Cheng XD, Xie X, Lü WG.

Zhonghua Yi Xue Za Zhi. 2012 Jul 17;92(27):1926-8. Chinese.

PMID:
23134969
2.

Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.

Fu Y, Ye D, Chen H, Lu W, Ye F, Xie X.

Gynecol Oncol. 2007 Apr;105(1):66-73. Epub 2007 Jan 17.

PMID:
17234259
3.

Overexpression of glycogen synthase kinase-3 in ovarian carcinoma cells with acquired paclitaxel resistance.

Fu Y, Hu D, Qiu J, Xie X, Ye F, Lu WG.

Int J Gynecol Cancer. 2011 Apr;21(3):439-44. doi: 10.1097/IGC.0b013e31820d7366.

PMID:
21436692
4.

Downregulation of miR-17~92 Expression Increase Paclitaxel Sensitivity in Human Ovarian Carcinoma SKOV3-TR30 Cells via BIM Instead of PTEN.

Shuang T, Shi C, Chang S, Wang M, Bai CH.

Int J Mol Sci. 2013 Feb 8;14(2):3802-16. doi: 10.3390/ijms14023802.

5.

Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.

Pan L, Tong Y, Jin Y, Zhou S, Zhang Y, Yang X, Mao N.

Chin Med J (Engl). 2001 Sep;114(9):929-32.

PMID:
11780384
6.
7.
8.

[RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM].

Deng KX, Zhong L, Jiang MX, Wang PL, Chen Y.

Zhonghua Fu Chan Ke Za Zhi. 2005 Dec;40(12):836-9. Chinese.

PMID:
16412331
9.

[Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].

Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.

Zhonghua Fu Chan Ke Za Zhi. 2010 Sep;45(9):691-8. Chinese.

PMID:
21092551
10.

Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer.

Wang H, Fan L, Xia X, Rao Y, Ma Q, Yang J, Lu Y, Wang C, Ma D, Huang X.

Int J Gynecol Cancer. 2012 Jun;22(5):755-61. doi: 10.1097/IGC.0b013e3182540284.

PMID:
22635028
11.

[Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].

Zhang X, Li N, Wang YH, Huang Y, Xu NZ, Wu LY.

Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):174-7. Chinese.

PMID:
19615253
12.
13.

Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.

Ganta S, Amiji M.

Mol Pharm. 2009 May-Jun;6(3):928-39. doi: 10.1021/mp800240j.

PMID:
19278222
14.
15.

Establishment of paclitaxel-resistant cell line and the underlying mechanism on drug resistance.

Zhang J, Zhao J, Zhang W, Liu G, Yin D, Li J, Zhang S, Li H.

Int J Gynecol Cancer. 2012 Nov;22(9):1450-6. doi: 10.1097/IGC.0b013e31826e2382.

PMID:
23051955
16.

[Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM].

Deng KX, Zhong L, Jiang MX, Chen WX, Chen Y, He H.

Ai Zheng. 2005 Aug;24(8):945-50. Chinese.

PMID:
16086871
17.

Biological characteristics of Taxol‑resistant ovarian cancer cells and reversal of Taxol resistance by adenovirus expressing p53.

Liu Q, Sui R, Li R, Miao J, Liu J.

Mol Med Rep. 2015 Feb;11(2):1292-7. doi: 10.3892/mmr.2014.2784. Epub 2014 Oct 27.

PMID:
25351378
18.

Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells.

Kim SH, Juhnn YS, Song YS.

Ann N Y Acad Sci. 2007 Jan;1095:82-9.

PMID:
17404021
19.

Curcumin induces human SKOV3 cell apoptosis via the activation of Rho-kinase.

Yin Z, Sun J.

Eur J Gynaecol Oncol. 2014;35(4):433-7.

PMID:
25118487
20.

[Proteasome inhibitors sensitize ovarian cancer cells to paclitaxel induced apoptosis].

Weng DH, Li Y, Kong FF, Fan LS, Hu Y, Song XH, Xing H, Wang SX, Ma D.

Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):770-3. Chinese.

PMID:
19087546

Supplemental Content

Support Center